文献速递临床试验与 GCP流行病学与生物统计

GRASP试验统计分析计划:渐进性运动与最佳建议比较,联合或不联合皮质类固醇注射治疗肩袖疾病

Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: statistical analysis plan for the Getting it Right: Addressing Shoulder Pain (GRASP) 2 × 2 factorial multicentre randomised controlled trial.
PubMed 文献 · Trials · 2020-09-07

GRASP试验采用2×2析因设计,评估个体化渐进性运动与最佳建议比较,联合或不联合皮质类固醇注射,在肩袖疾病成人中的临床和成本效果。本文描述该试验的统计分析计划,包括样本量计算、主要和次要结局的统计模型、缺失数据处理及预设的敏感性和亚组分析,且在未知试验结果前完成。

要点

  • GRASP试验采用2×2析因设计比较渐进性运动与最佳建议,联合或不联合皮质类固醇注射。
  • 主要结局为12个月内肩痛和残疾指数(SPADI)总分平均差异。
  • 统计分析计划预设了样本量计算、统计模型、缺失数据处理及敏感性分析。

核心结论

  • 发表GRASP试验的统计分析计划旨在减少结局报告偏倚风险并提高数据分析透明度。

研究设计与样本

  • GRASP为多中心随机对照试验,采用2×2析因设计,对象为≥18岁新发肩袖疾病相关肩痛成人。
  • 受试者按中心化计算机生成1:1:1:1比例随机分配至四组干预之一。
  • 四组干预分别为:渐进性运动(最多6次物理治疗)、最佳建议(1次物理治疗)、肩峰下皮质类固醇注射后渐进性运动、肩峰下皮质类固醇注射后最佳建议。

关键数值与推荐

  • 主要结局为12个月内SPADI总分平均差异。
  • 次要结局包括SPADI疼痛和功能子域、健康相关生活质量(EQ-5D-5L)、睡眠障碍、恢复活动、整体变化印象、卫生资源使用、自付费用和工作残疾。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Getting it Right: Addressing Shoulder Pain (GRASP) trial assesses the clinical and cost-effectiveness of individually tailored, progressive exercise compared with best practice advice, with or without corticosteroid injection, in adults with a rotator cuff disorder. This article describes the statistical analysis plan for the GRASP randomised controlled trial. METHODS/DESIGN: GRASP is a multicentre randomised controlled trial using a 2 × 2 factorial design. Adults aged ≥ 18 years with a new episode of shoulder pain related to a rotator cuff disorder, not currently receiving physiotherapy or being considered for surgery, are randomised (centralised computer-generated 1:1:1:1 allocation ratio) to one of four interventions: (1) progressive exercise (up to 6 physiotherapy sessions), (2) best practice advice (one physiotherapy session), (3) subacromial corticosteroid injection then progressive exercise and (4) subacromial corticosteroid injection then best practice advice. The primary outcome is the mean difference in Shoulder Pain and Disability Index (SPADI) total score over 12 months. Secondary outcomes are as follows: pain and function SPADI subdomains, health-related quality of life (EuroQol EQ-5D-5L), sleep disturbance, return to activity, global impression of change, health resource use, out-of-pocket expenses and work disability. Here, we describe in detail the following: sample size calculation, descriptive statistics of the primary and secondary outcomes, statistical models used for the analysis of the main outcomes, handling of missing data, planned sensitivity and subgroup analyses. This pre-specified statistical analysis plan was written and submitted without prior knowledge of the trial results. DISCUSSION: Publication of the statistical analysis plan for the GRASP trial aims to reduce the risk of outcome reporting bias and increase transparency of the data analysis. Any deviations or changes to the current SAP will be described and justified in the final study report and any results publications. TRIAL REGISTRATION: International Standard Randomised Controlled Trial Number ISRCTN16539266 . Registered on 14 June 2016. EudraCT number 2016-002991-28. Registered on 12 June 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Marian IR, Hopewell S, Keene DJ, et al. Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: statistical analysis plan for the Getting it Right: Addressing Shoulder Pain (GRASP) 2 × 2 factorial multicentre randomised controlled trial. Trials. 2020. PMID: 32894159. doi:10.1186/s13063-020-04704-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。